![](/img/cover-not-exists.png)
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting : Results from a randomized, double-blind, placebo-controlled trial in Latin America
Sergio Poli-Bigelli, Jose Rodrigues-Pereira, Alexandra D. Carides, Guoguang Julie Ma, Krista Eldridge, Anita Hipple, Judith K. Evans, Kevin J. Horgan, Francesca Lawson, On behalf of the Aprepitant ProVolume:
97
Year:
2003
Language:
english
Pages:
9
DOI:
10.1002/cncr.11433
File:
PDF, 114 KB
english, 2003